Search Results - "Abounasr, Aya"

Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis by Palanichamy, Arumugam, Apeltsin, Leonard, Kuo, Tracy C, Sirota, Marina, Wang, Shengzhi, Pitts, Steven J, Sundar, Purnima D, Telman, Dilduz, Zhao, Lora Z, Derstine, Mia, Abounasr, Aya, Hauser, Stephen L, von Büdingen, H-Christian

“…In multiple sclerosis (MS), lymphocyte--in particular B cell--transit between the central nervous system (CNS) and periphery may contribute to the maintenance…”
Get more information

Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients by Eggers, Erica L, Michel, Brady A, Wu, Hao, Wang, Sheng-Zhi, Bevan, Carolyn J, Abounasr, Aya, Pierson, Natalie S, Bischof, Antje, Kazer, Max, Leitner, Elizabeth, Greenfield, Ariele L, Demuth, Stanislas, Wilson, Michael R, Henry, Roland G, Cree, Bruce Ac, Hauser, Stephen L, von Büdingen, H-Christian

“…A role of B cells in multiple sclerosis (MS) is well established, but there is limited understanding of their involvement during active disease. Here, we…”
Get full text

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial by Green, Ari J, Gelfand, Jeffrey M, Cree, Bruce A, Bevan, Carolyn, Boscardin, W John, Mei, Feng, Inman, Justin, Arnow, Sam, Devereux, Michael, Abounasr, Aya, Nobuta, Hiroko, Zhu, Alyssa, Friessen, Matt, Gerona, Roy, von Büdingen, Hans Christian, Henry, Roland G, Hauser, Stephen L, Chan, Jonah R

“…Multiple sclerosis is a degenerative inflammatory disease of the CNS characterised by immune-mediated destruction of myelin and progressive neuroaxonal loss…”
Get full text

Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients by Palanichamy, Arumugam, Jahn, Sarah, Nickles, Dorothee, Derstine, Mia, Abounasr, Aya, Hauser, Stephen L, Baranzini, Sergio E, Leppert, David, von Büdingen, H-Christian

“…In multiple sclerosis (MS), B cell-depleting therapy using monoclonal anti-CD20 Abs, including rituximab (RTX) and ocrelizumab, effectively reduces disease…”
Get full text

Rare Presentation of Paroxysmal High B-Pee by Bradshaw, Christina, Abounasr, Aya, Brunsing, Ryan L., Kao, Chia-Sui, Reejhsinghani, Risheen, Annes, Justin P., Chung, Benjamin I., Mihm, Frederick, Bhalla, Vivek

Get full text

Rare Presentation of Paroxysmal High B-Pee by Bradshaw, Christina, Abounasr, Aya, Brunsing, Ryan L., Kao, Chia-Sui, Reejhsinghani, Risheen, Annes, Justin P., Chung, Benjamin I., Mihm, Frederick, Bhalla, Vivek

Get full text

Rituximab efficiently depletes increased CD20 expressing T cells in multiple sclerosis patients1 by Palanichamy, Arumugam, Jahn, Sarah, Nickles, Dorothee, Derstine, Mia, Abounasr, Aya, Hauser, Stephen L., Baranzini, Sergio E., Leppert, David, von Büdingen, H.-Christian

“…In multiple sclerosis (MS 4 ) B cell depleting therapy using monoclonal anti-CD20 antibodies, including rituximab (RTX) and ocrelizumab (OCR), effectively…”
Get full text

EDSS and MSFC Incompletely Capture Patient Reported Disability in a Longitudinal Cohort of Patients with Multiple Sclerosis (P5.014) by Bevan, Carolyn, Gourraud, Pierre-Antoine, Bucci, Monica, Schlaeger, Regina, Gomez, Refujia, Ciocca, Caroline, Kanner, Rachel, Stern, William, Evangelista, Alan, Arnow, Samuel, Abounasr, Aya, Santaniello, Adam, Gelfand, Jeffrey, Von Budingen, H., Green, Ari, Goodin, Douglas, Baranzini, Sergio, Hauser, Stephen, Henry, Roland, Cree, Bruce

“…Abstract only…”
Get full text